Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Kingdom, and Switzerland. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Metrics to compare | ONWD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipONWDPeersSector | |
---|---|---|---|---|
P/E Ratio | −5.2x | −2.0x | −0.5x | |
PEG Ratio | −0.16 | −0.05 | 0.00 | |
Price/Book | 3.8x | 2.1x | 2.6x | |
Price / LTM Sales | 106.3x | 2.1x | 3.3x | |
Upside (Analyst Target) | 238.2% | 51.6% | 40.3% | |
Fair Value Upside | Unlock | 18.9% | 5.1% | Unlock |